Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-31

FDA Approved: GLIMEPIRIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)

View source ↗

Summary

FDA approved a supplemental application for glimepiride from Dr. Reddy's Laboratories Limited. Glimepiride is a generic drug used to treat type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glimepiride (glimepiride)

Snippet

SUPPL AP for GLIMEPIRIDE (GLIMEPIRIDE)